Systemic use of propranolol in the treatment of infantile hemangiomas Uso sist¿mico de propranolol en el tratamiento de hemangiomas infantiles uri icon


  • The capillary or infantile hemangiomas (IH) are the most common benign tumors in the pediatric population. Recent reports have indicated the efficacy of systemic propranolol in the treatment of these lesions with good results and few adverse effects. A prospective, interventional, non-comparative series of five Mexican patients treated with propranolol (2 a 3 mg/kg/day) for 2-12 months is presented. The five patients have orbital or periocular involvement. The follow-up of the hemangiomas is documented with photographs as well as the incidence of the side effects presented with the treatment. Despite the fact that the propranolol's mechanism of action hasn't been completely elucidated it is concluded that propranolol is an effective treatment, easy to get and with enough safety to be administered in an ambulatory setting.

Publication date

  • November 1, 2011